Gerhard Bodo

Title: Gerhard Bodo: Innovator in Biologically Active Proteins

Introduction

Gerhard Bodo is a distinguished inventor based in Vienna, Austria. He has made significant contributions to the field of biologically active proteins, holding a total of 7 patents. His work has advanced the understanding and application of various proteins, particularly in the medical and biotechnological sectors.

Latest Patents

Among his latest patents is the invention related to vascular anticoagulant proteins and the DNA that codes for them. This invention focuses on biologically active proteins, the DNA molecules coding for them, processes for preparing them, and their various uses. Another notable patent is the process and vector for expressing alpha-interferon in E. coli. This patent provides methods and vectors for expressing interferon-alpha (IFN-α) proteins in E. coli, utilizing a vector that comprises an IFN-α sequence fused to an E. coli heat-stable enterotoxin signal sequence (STII) under the control of the E. coli phosphatase (phoA) promoter. This innovative approach allows for high levels of correctly-folded and processed, biologically active IFN-α polypeptides.

Career Highlights

Gerhard Bodo has worked with prominent companies in the biotechnology sector, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim GmbH. His experience in these organizations has contributed to his expertise in the development of biologically active proteins.

Collaborations

Throughout his career, Gerhard has collaborated with notable colleagues such as Edgar Falkner and Ingrid Maurer-Fogy. These partnerships have further enriched his research and innovations in the field.

Conclusion

Gerhard Bodo's contributions to the field of biologically active proteins and his impressive portfolio of patents underscore his role as a leading inventor in biotechnology. His work continues to influence advancements in medical and biotechnological applications.